Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Greenbrook TMS Announces Dates for Its Second Quarter 2019 Financial Results

GBNHF

TORONTO

Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) will release its 2019 second quarter operational and financial results after market hours on August 6, 2019.

Second Quarter 2019 Conference Call Details

Bill Leonard, President and Chief Executive Officer and Erns Loubser, Chief Financial Officer, will host a conference call at 10:00 a.m. (Eastern Time) on August 7, 2019 to discuss the financial results for the quarter.

Dial in Numbers:

Toll Free North America: 1-866-521-4909

Toronto: 647-427-2311

Webcast:

For more information or to listen to the call via webcast, please visit:

https://www.greenbrooktms.com/investors/events.htm

Conference Call Replay

Toll Free (North America): 1-800-585-8367

Toronto: 416-621-4642

Passcode: 9964329

The conference call replay will be available from 1:00 p.m. (Eastern Time) on August 7, 2019, until 23:59 p.m. (Eastern Time) on September 7, 2019.

About Greenbrook TMS Inc.

Operating through 75 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 250,000 TMS treatments to over 6,500 patients struggling with depression.

Erns Loubser
Chief Financial Officer, Treasurer and Corporate Secretary
Greenbrook TMS Inc.

Linda Armstrong
Investor Relations
Greenbrook TMS Inc.

Contact Information:
investorrelations@greenbrooktms.com
1-855-797-4867